DAYTON, Ohio (WDTN) – Dayton Children’s Hospital will now have access to a clinical trial aimed at improving quality of life and survival rates from several types of malignant brain tumors, the hospital announced Monday.
The clinical trial, called the Head Start 4 protocol, aims to find better treatments and outcomes for young children newly diagnosed with the most common brain tumors such as medulloblastoma and others. The protocols are centered around personalized medicine and helps understand how the genetic material affects health.
As of Monday, 95 children are enrolled in the clinical trial with room to enroll 155 more, according to the hospital.
“We are always working to find ways to make life a little better for our children,” says Ayman El-Sheik, MD, chief, division of hematology and oncology at Dayton Children’s Hospital. “It is through research and trials like this that we can continually offer a better solution tomorrow than we did yesterday.”
- 2020 Masters tournament to tee off in November with no patrons or guests
- Coroner identifies woman hit, killed by driver in Dayton
- Poll: More than 50 percent of Ohio restaurants could close within 9 months
- Stein Mart files for bankruptcy amid pandemic turmoil
- Kentucky Derby races on with updated public safety measures in place